Simvastatin in Critically Ill Patients with Covid-19
The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.
Scientific Papers
Article
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults.
Article
Scientific Papers
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
Previous comparative analyses of people admitted to hospital for COVID-19 versus influenza evaluated the risk of death, hospital readmission, and a narrow set of health outcomes up to 6 months following infection.
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The NIRSE-GAL study shows in real time the evolution of the coverage achieved by immunisation with Nirsevimab in children and compares RSV admissions in different population groups of children and adults in Galicia in Spain with previous years.
First results in using new tools to tackle respiratory syncytial virus
Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?
Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: the prospective Maastricht Intensive Care Covid Cohort
Among 232 mechanically ventilated COVID-19 patients, 21.1% had known diabetes mellitus, whereas 16.9% in wave 2 had unknown diabetes mellitus.
Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
News
Scientific Papers
Article
Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into action
Accurate information on the health burden of vaccine-preventable infections (VPIs) is needed to support evidence-informed vaccine policy recommendations and programmes in Europe.
Article
News
Scientific Papers
The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe
People can be at risk of getting and spreading serious vaccine-preventable infectious diseases throughout their lives and can therefore benefit from a lifelong approach to vaccination.
Sequential vaccinations with divergent H1N1influenza virus strains induce multi-H1 cladeneutralizing antibodies in swine
Vaccines that protect against any H1N1 influenza A virus strain would beadvantageous for use in pigs and humans.
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
